Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

STOK

Stoke Therapeutics Inc

May 29 • 04:00PM ET

30.91

-0.70 -2.21 %

Healthcare • Biotechnology • USA • Small • NASD

Peers: KYMR RYTM APGE NUVL VKTX BMRN INCY KRYS AXSM NBIX

| Held by: VTI XBI IWM VXF IWO IBB VTWO SCHA DFAS FYC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-2.84	Insider Own	20.99%	Shs Outstand	62.24M	Perf Week	4.18%
Market Cap	1.93B	Forward P/E	-	EPS next Y	-3.12	Insider Trans	-1.12%	Shs Float	49.21M	Perf Month	-4.66%
Enterprise Value	1.59B	PEG	-	EPS next Q	-0.77	Inst Own	107.10%	Short Float	26.25%	Perf Quarter	-15.11%
Income	-169.77M	P/S	60.01	EPS this Y	-2584.72%	Inst Trans	6.21%	Short Ratio	18.31	Perf Half Y	3.66%
Sales	32.08M	P/B	4.87	EPS next Y	3.24%	ROA	-39.94%	Short Interest	12.92M	Perf YTD	-2.61%
Book/sh	6.34	P/C	5.60	EPS next 5Y	-	ROE	-45.58%	52W High	40.22 -23.15%	Perf Year	217.68%
Cash/sh	5.52	P/FCF	-	EPS past 3/5Y	64.49% 40.50%	ROIC	-42.88%	52W Low	9.34 230.94%	Perf 3Y	183.06%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	145.89% -	Gross Margin	87.07%	Volatility	4.47% 4.98%	Perf 5Y	-22.06%
Dividend TTM	-	EV/Sales	49.41	EPS Y/Y TTM	-439.48%	Oper. Margin	-577.46%	ATR (14)	1.56	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	8.99	Sales Y/Y TTM	-83.20%	Profit Margin	-529.20%	RSI (14)	44.54	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	8.99	EPS Q/Q	-141.72%	SMA20	-1.99%	Beta	1.18	Target Price	45.10
Payout	-	Debt/Eq	0.01	Sales Q/Q	-96.07%	SMA50	-6.42%	Rel Volume	0.77	Prev Close	31.61
Employees	170	LT Debt/Eq	0.00	Earnings	May 07 AMC	SMA200	3.08%	Avg Volume	705.36K	Price	30.91
IPO	Jun 19, 2019	Option/Short	Yes / Yes	EPS/Sales Surpr.	2.17% -3.92%	Trades		Volume	543,574	Change	-2.21%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)